Article History
Received: 14 July 2023
Accepted: 26 October 2023
First Online: 20 December 2023
Declarations
:
: NG received research funding from the Fonds de la Recherche Scientifique (FNRS), Fonds Erasme pour la Recherche Médicale, and INNOVIRIS. NG received royalties for authoring a chapter for MedLink Neurology. NG served on speakers’ bureau and advisory board for UCB Pharma and Angelini Pharma AR has nothing to disclose. JC is supported by grant funding from the NIH R01 NS106014 and the McDonnell Foundation. JC is a minority shareholder at iCE Neurosystems.